Analyst Activity – Jefferies Group Reiterates Buy on Scpharmaceuticals (NASDAQ:SCPH)

Analyst Ratings For Scpharmaceuticals (NASDAQ:SCPH)

Story continues below

Today, Jefferies Group reiterated its Buy rating on Scpharmaceuticals (NASDAQ:SCPH) with a price target of $26.00.

Some recent analyst ratings include

  • 3/21/2018-Jefferies Group Reiterated Rating of Buy.
  • 12/12/2017-Leerink Swann initiated coverage with a Outperform rating.
  • 12/12/2017-BMO Capital Markets initiated coverage with a Outperform rating.

  • On 11/21/2017 5Am Partners Iv, Llc, Major Shareholder, bought 654,762 with an average share price of $14.00 per share and the total transaction amounting to $9,166,668.00.

Recent Trading Activity for Scpharmaceuticals (NASDAQ:SCPH)
Shares of Scpharmaceuticals closed the previous trading session at 12.88 down -0.45 3.38% with 12.70009994506836 shares trading hands.

An ad to help with our costs